People who have been diagnosed with moderate-to-severe atopic dermatitis (eczema) for at least 3 years and are aged 12 and older may qualify to receive investigational medication at no cost throughout the research study. There is no cost to participate, and participants will be reimbursed for travel related expenses.
To be eligible, participants must:
- Be struggling to control their atopic eczema despite topical (applied to the skin) treatment.
- Have at least 10% of their body surface area covered in eczema (10 palm sized patches).
Email Tina Craig, Clincal Research Coordinator at DermEffects to register.